Jacob Giehm Mikkelsen is a Professor at the Department of Biomedicine, Aarhus University.

Jacob is a trained retrovirologist with >25 years of experience in gene transfer and virus-based gene delivery technologies with focus on gene therapy, genetic engineering, and more recently genome editing using CRISPR. Over the last 10 years, Jacob’s lab has fronted the development of lentivirus-derived nanoparticles for delivery of genome-modifying proteins and ribonucleoprotein complexes. Part of his current research focuses on providing a better understanding of virus-based protein delivery and cell-vehicle interactions to develop enveloped CRISPR/Cas delivery technologies further and bring these new tools closer to the clinic.